CoChat
Sign Up
Cited by 226Dialysis and Renal Disease ManagementCardiovascular Function and Risk FactorsChronic Kidney Disease and Diabetes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Long-term evolution of cardiomyopathy in dialysis patients

Open access
Foley, Robert N., Parfrey, Patrick S., Kent, Gloria M., Harnett, John D., Murray, David C., Barre, Paul E.·1998·Kidney International
DOI 10.1046/j.1523-1755.1998.00154.x
Open this paper in CoChat — free accountOpen PDF

Abstract

Background Left ventricular enlargement is very common at the inception of dialysis therapy, and highly predictive of future cardiac morbidity and mortality. It is not known whether cardiac size increases further while on dialysis therapy and whether potentially reversible risk factors for later progression can be identified. METHODS; Baseline and yearly echocardiograms were performed in a prospective inception cohort of 433 dialysis patients. The mean patient follow-up was 41 months; 29 patients had four consecutive echocardiograms at yearly intervals.Results The patient subset with four echocardiograms was older (58 vs. 51 years, P = 0.02) and had a lower mass ventricular mass index (128 vs. 149 g/m2, P = 0.02) than the parent group. Using repeated measures analysis of variance, applied to those with four echocardiograms, there were progressive increases over time in posterior wall thickness (P = 0.015), left ventricular end-diastolic diameter, left ventricular mass index (P = 0.001), and cavity volume index (P = 0. 001). Mass-to-volume ratios did not change. The biggest changes in mass (18 g/m2 - 14%)and volume index (13 ml/m2 - 18%) occurred between baseline and year 1, although increases in both were seen after year 1. Hemodialysis versus peritoneal dialysis (41 g/m2, P = 0.008) and anemia (10 g/m2 per 1 g/dl drop in hemoglobin, P = 0.02) were associated with progressive left ventricular enlargement, but only within the first year of dialysis therapy. The left ventricular enlargement seen after year 1 was independent of anemia, blood pressure, serum albumin and mode of dialysis.Conclusions Progressive cardiac enlargement, particularly left ventricular dilation with compensatory hypertrophy, continues after starting dialysis therapy. Most of the additional cardiac enlargement seems to occur in the first year of dialysis therapy, suggesting that intervention beyond one year may be relatively ineffective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1523-1755.1998.00154.x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 226

Related

See all

Metadata

Authors
Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barre, P. E.
Affiliations
Memorial University of Newfoundland (CA)
Corresponding author
Foley, Robert N.
Venue
Kidney International
Publisher
Elsevier BV
Published
1998-11
Volume
54
Issue
5
Pages
1720-1725
ISSN
0085-2538 (ISSN-L)
DOI
10.1046/j.1523-1755.1998.00154.x
OpenAlex
W2130476101
Cited by
226
References
39
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 15 · 2014: 2 · 2013: 3 · 2012: 13
FWCI
7.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Kidney International (publishedVersion)
  • PubMed (publishedVersion)
Funders
Memorial University of Newfoundland
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
left ventricular hypertrophy, left ventricular dilatation, dialysis patients, hemodialysis, peritoneal dialysis, anemia, left ventricular mass index, left ventricular end-diastolic diameter, cardiac remodeling, echocardiography
MeSH terms
Blood Pressure, Echocardiography, Renal Dialysis, Humans, Middle Aged, Prospective Studies, Hypertrophy, Left Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review